MESTRONI, LUISA
 Distribuzione geografica
Continente #
NA - Nord America 7.058
EU - Europa 4.286
AS - Asia 3.620
Continente sconosciuto - Info sul continente non disponibili 451
SA - Sud America 449
AF - Africa 106
OC - Oceania 6
Totale 15.976
Nazione #
US - Stati Uniti d'America 6.912
SG - Singapore 1.331
PL - Polonia 1.265
IT - Italia 1.099
CN - Cina 797
VN - Vietnam 367
BR - Brasile 346
SE - Svezia 344
HK - Hong Kong 335
DE - Germania 294
BD - Bangladesh 235
FR - Francia 224
NL - Olanda 186
KR - Corea 174
GB - Regno Unito 169
FI - Finlandia 152
RU - Federazione Russa 117
UA - Ucraina 102
IN - India 80
TR - Turchia 79
CA - Canada 76
BG - Bulgaria 72
IE - Irlanda 72
JP - Giappone 40
AR - Argentina 38
CH - Svizzera 33
MX - Messico 33
MA - Marocco 32
ES - Italia 28
BE - Belgio 25
ID - Indonesia 25
ZA - Sudafrica 25
AT - Austria 20
IQ - Iraq 19
SA - Arabia Saudita 18
PK - Pakistan 17
EC - Ecuador 14
IR - Iran 12
CL - Cile 11
CO - Colombia 11
RS - Serbia 11
AE - Emirati Arabi Uniti 10
VE - Venezuela 9
GR - Grecia 8
JM - Giamaica 8
JO - Giordania 8
KG - Kirghizistan 8
PH - Filippine 8
RO - Romania 8
TN - Tunisia 8
KE - Kenya 7
NP - Nepal 7
PT - Portogallo 7
CR - Costa Rica 6
DZ - Algeria 6
EG - Egitto 6
IL - Israele 6
LT - Lituania 6
MY - Malesia 6
SN - Senegal 6
TT - Trinidad e Tobago 6
AU - Australia 5
AZ - Azerbaigian 5
HU - Ungheria 5
LB - Libano 5
LV - Lettonia 5
PE - Perù 5
PY - Paraguay 5
SI - Slovenia 5
UZ - Uzbekistan 5
AL - Albania 4
AO - Angola 4
BA - Bosnia-Erzegovina 4
BO - Bolivia 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
EU - Europa 4
NO - Norvegia 4
UY - Uruguay 4
DK - Danimarca 3
KW - Kuwait 3
NG - Nigeria 3
TH - Thailandia 3
TW - Taiwan 3
BH - Bahrain 2
EE - Estonia 2
GA - Gabon 2
GE - Georgia 2
GT - Guatemala 2
HN - Honduras 2
KZ - Kazakistan 2
LK - Sri Lanka 2
MD - Moldavia 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
AG - Antigua e Barbuda 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
Totale 15.507
Città #
Warsaw 1.181
Ashburn 891
Singapore 835
Fairfield 498
Chandler 454
San Jose 357
Woodbridge 346
Hong Kong 324
Houston 280
Ann Arbor 268
Chicago 232
Wilmington 227
Beijing 218
Trieste 218
Seattle 201
Cambridge 185
Los Angeles 178
Seoul 162
Dallas 148
Council Bluffs 137
Hefei 125
Jacksonville 113
Ho Chi Minh City 112
Boardman 110
Princeton 106
Santa Clara 92
Milan 88
Hanoi 82
Helsinki 79
Columbus 78
Lauterbourg 76
New York 71
Sofia 69
Dublin 67
Rome 65
Zgierz 64
Munich 63
London 60
Frankfurt am Main 58
Salt Lake City 50
Buffalo 49
Izmir 49
Moscow 48
São Paulo 41
Amsterdam 40
Dearborn 40
The Dalles 38
Dong Ket 30
San Diego 30
Tokyo 30
Redwood City 29
Düsseldorf 28
Nuremberg 28
Phoenix 28
Elk Grove Village 27
Tampa 27
Atlanta 25
Guangzhou 25
Lappeenranta 25
Brussels 24
Redondo Beach 23
Orem 22
Turku 22
Bremen 21
Miano 21
Toronto 21
Bern 20
Casablanca 20
Falls Church 20
Memphis 19
Miami 19
Turin 19
Da Nang 18
Denver 18
Naples 18
Lancaster 17
Poplar 17
Redmond 17
Shanghai 17
Sterling 17
Washington 17
Grafing 16
Venice 15
Chennai 14
Johannesburg 14
Nanjing 14
Palermo 14
Vienna 14
Montreal 13
North Bergen 13
Stockholm 13
Bari 11
Bexley 11
Boydton 11
Brooklyn 11
Des Moines 11
Madrid 11
San Francisco 11
Baghdad 10
Belgrade 10
Totale 10.269
Nome #
Current understanding of the role of cytoskeletal cross-linkers in the onset and development of cardiomyopathies 521
A Review of the Giant Protein Titin in Clinical Molecular Diagnostics of Cardiomyopathies 512
Natural History of Dilated Cardiomyopathy in Children 436
Role of Titin Missense Variants in Dilated Cardiomyopathy 427
Inquadramento e gestione delle cardiomiopatie: il protocollo della Cardiologia di Trieste 417
Filamin C Truncation Mutations Are Associated With Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell–Cell Adhesion Structures 405
Improving cardiac myocytes performance by carbon nanotubes platforms 391
FLNC Gene Splice Mutations Cause Dilated Cardiomyopathy 389
Knock Down of Plakophillin 2 Dysregulates Adhesion Pathway through Upregulation of miR200b and Alters the Mechanical Properties in Cardiac Cells 334
Cellular biomechanics impairment in keratinocytes is associated with a C-terminal truncated desmoplakin: An atomic force microscopy investigation 293
Altered microtubule structure, hemichannel localization and beating activity in cardiomyocytes expressing pathologic nuclear lamin A/C 292
Biomechanical defects and rescue of cardiomyocytes expressing pathologic nuclear lamins 290
Historical Terminology, Classifications, and Present Definition of DCM. 276
The giant protein Titin’s role in cardiomyopathy: genetic, transcriptional, and post translational modifications of TTN and their contribution to cardiac disease 272
Carbon nanotube facilitation of myocardial ablation with radiofrequency energy 260
Chapter 5: Genetics of Dilated Cardiomyopathy: Current Knowledge and Future Perspectives 259
Easy fabrication of aligned PLLA nanofibers-based 2D scaffolds suitable for cell contact guidance studies 258
Genetics of Dilated Cardiomyopathy: Clinical Implications 250
Titin and desmosomal genes in the natural history of arrhythmogenic right ventricular cardiomyopathy 235
Phenotypic Expression, Natural History and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating Variants 235
The role of clinical observation: Red flag 6-left ventricular non-compaction 234
Arrhythmogenic right ventricular cardiomyopathy: Arrhythmogenic right ventricular cardiomyopathy: Clinical assessment and differential diagnosis 233
Genetic and Phenotypic Characterization of Nexilin (NEXN)-Related Cardiomyopathy: Results From a Multicentric Study 231
Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy 229
The role of clinical observation: Red flag 7-syndromic and multi-system cardiomyopathies 225
Prevalence and evolution of right ventricular dysfunction among different genetic backgrounds in dilated cardiomyopathy 223
Association of Titin Variations with Late-Onset Dilated Cardiomyopathy 221
Contemporary survival trends and aetiological characterization in non-ischaemic dilated cardiomyopathy 217
Early Arrhythmic Events in Idiopathic Dilated Cardiomyopathy 208
Clinical Risk Score to Predict Pathogenic Genotypes in Patients With Dilated Cardiomyopathy 205
Sex differences in natural history of cardiovascular magnetic resonance- and biopsy-proven lymphocytic myocarditis 194
Trattamento dello scompenso cardiaco con terapia genica: i risultati inattesi del trial CUPID 2 192
Impact of DCM-Causing Genetic Background on Long-Term Response to Cardiac Resynchronization Therapy 190
Antiarrhythmic therapy and risk of cumulative ventricular arrhythmias in arrhythmogenic right ventricle cardiomyopathy 186
Clinical features and outcomes in carriers of pathogenic desmoplakin variants 185
Danon Disease-Associated LAMP-2 Deficiency Drives Metabolic Signature Indicative of Mitochondrial Aging and Fibrosis in Cardiac Tissue and hiPSC-Derived Cardiomyocytes 185
Molecular and Cellular Mechanisms in Heart Failure 184
Atomic Force Microscopy (AFM) applications in arrhythmo-genic cardiomyopathy 183
Viscoelastic behavior of cardiomyocytes carrying LMNA mutations 177
SCN5A Mutations Associate With Arrhythmic Dilated Cardiomyopathy and Commonly Localize to the Voltage-Sensing Mechanism. 176
Introduction 176
Arrhythmic Risk Stratification of Carriers of Filamin C Truncating Variants 175
Clinical Spectrum of PRKAG2 Syndrome 173
A novel tool for arrhythmic risk stratification in desmoplakin gene variant carriers 164
Cellular Biomechanic Impairment in Cardiomyocytes Carrying the Progeria Mutation: An Atomic Force Microscopy Investigation 163
Prognostic role of exercise intensity in familial Filamin C truncating variants 160
The response to cardiac resynchronization therapy in LMNA cardiomyopathy 159
AFM macro-probes to investigate whole 3D cardiac spheroids 156
Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Left Ventricular Cardiomyopathies 156
Lamin A/C Cardiomyopathy: Implications for Treatment 150
The electrocardiogram in the diagnosis and management of patients with dilated cardiomyopathy 149
Carbon Nanotubes for Cardiac Applications 143
A Systematic Analysis of the Clinical Outcome Associated with Multiple Reclassified Desmosomal Gene Variants in Arrhythmogenic Right Ventricular Cardiomyopathy Patients 141
The Arrhythmic Phenotype in Cardiomyopathy 141
Ankyrin-B dysfunction predisposes to arrhythmogenic cardiomyopathy and is amenable to therapy 137
Risk Stratification in Arrhythmic Right Ventricular Cardiomyopathy Without Implantable Cardioverter-Defibrillators 136
Microfabricated cantilevers for parallelized cell-cell adhesion measurements 135
Investigations of cardiac fibrosis rheology by in vitro cardiac tissue modeling with 3D cellular spheroids 134
Activation of PDGFRA signaling contributes to filamin C–related arrhythmogenic cardiomyopathy 129
The genetic architecture of Plakophilin 2 cardiomyopathy 124
null 121
Arrhythmogenic right ventricular cardiomyopathy: From genetics to diagnostic and therapeutic challenges 121
Compromised Biomechanical Properties, Cell–Cell Adhesion and Nanotubes Communication in Cardiac Fibroblasts Carrying the Lamin A/C D192G Mutation 116
CARBON NANOTUBE SCAFFOLDS FOR CARDIAC TISSUE ENGINEERING 114
Neonatal rat ventricular myocytes interfacing conductive polymers and carbon nanotubes 112
null 112
Gold Nanoparticle-Functionalized Reverse Thermal Gel for Tissue Engineering Applications 107
FLNC truncations cause arrhythmogenic right ventricular cardiomyopathy 106
null 103
Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia/cardiomyopathy suggest non-canonical mechanisms for disease pathogenesis 102
Valutazione dell’ereditarietà e analisi molecolare alla luce delle nuove linee guida europee sulla cardiomiopatia ipertrofica 102
Genetic causes of dilated cardiomyopathy 101
The Sarcomeric Spring Protein Titin: Biophysical Properties, Molecular Mechanisms, and Genetic Mutations Associated with Heart Failure and Cardiomyopathy 97
Prediction and prognostic role of left ventricular systolic dysfunction in family screening for dilated cardiomyopathy and non-dilated left ventricular cardiomyopathy 96
Titin-related familial dilated cardiomyopathy: factors associated with disease onset 94
Myocardial Recovery in Recent Onset Dilated Cardiomyopathy: Role of CDCP1 and Cardiac Fibrosis 86
Impact of genotype-phenotype associations on prognosis in dilated cardiomyopathy 76
Risks of Ventricular Arrhythmia and Heart Failure in Carriers of RBM20 Variants 72
Integrated role of cardiac magnetic resonance and genetics in predicting left ventricular reverse remodelling in dilated and non-dilated cardiomyopathy 71
Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin Variants 61
Sex Differences in Prognosis of Patients With Genetic Dilated Cardiomyopathy 53
Future development of arrhythmogenic risk scores in patients with heart failure and inherited dilated cardiomyopathy. A scientific statement of the Heart Failure Association of the ESC 43
Twenty-Five-Year Follow-Up of the MDDC1 Family: A LMNA Gene Variant Associated With Dilated Cardiomyopathy With Variable Skeletal Muscle Involvement 32
RBM20 Truncating Variants and Human Cardiomyopathy 20
External validation of the DSP-Risk Score for prediction of clinically significant ventricular arrhythmias in primary prevention patients with desmoplakin cardiomyopathy associated genetic variants 15
Sex and Age Specific Genetic Risk Across the Dilated and Arrhythmogenic Cardiomyopathy Spectrum: Insights From the SHaRe Registry 9
Variant Site-Specific Natural History of Titin-Induced Cardiomyopathy: An International Multicenter Registry 3
Totale 15.976
Categoria #
all - tutte 44.627
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.627


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022873 0 79 64 47 52 82 47 27 103 91 56 225
2022/20231.250 105 172 136 198 112 197 17 112 124 18 40 19
2023/2024902 58 49 66 67 73 118 143 128 18 26 93 63
2024/20252.174 24 151 200 169 183 157 119 124 270 305 238 234
2025/20266.024 865 345 541 545 481 436 726 198 539 678 393 277
2026/2027429 313 116 0 0 0 0 0 0 0 0 0 0
Totale 15.976